Kosmos

The Kosmos device is an Ultrasonic Pulsed Doppler Imaging System designed for non-invasive diagnostic medical imaging and assessment. It utilizes ultrasound wave propagation and the Doppler effect, supported by various transducer and software components, to visualize anatomical structures and evaluate physiological parameters like blood flow, particularly for cardiovascular applications.

The Kosmos device, manufactured by EchoNous, Inc., is identified as an Ultrasonic Pulsed Doppler Imaging System, further detailed by product codes indicating capabilities in pulsed echo ultrasound, diagnostic ultrasonic transducers, image processing, potential catheter guidance accessories, and cardiovascular image analysis software. Its primary purpose is to provide non-invasive medical diagnostic imaging. The methodology involves emitting ultrasound pulses via a transducer into the body, capturing the returning echoes to form images of internal structures, and utilizing the Doppler principle to assess dynamic physiological processes, such as blood flow velocity and direction, which is crucial for diagnosing a variety of medical conditions, particularly cardiovascular ones. The scientific basis of the Kosmos device relies on the principles of ultrasound physics, where high-frequency sound waves interact with bodily tissues of varying densities, reflecting back to the transducer. The pulsed Doppler technique enables the system to measure the velocity of moving reflectors, primarily red blood cells, by analyzing the frequency shift in the returning ultrasound signals. This allows for the non-invasive visualization of anatomical structures, evaluation of vascular health (including detection of stenoses or occlusions), and assessment of organ function, with a potential focus on cardiovascular applications indicated by its associated product codes. While specific clinical outcomes or detailed performance metrics are not in this document, its classification suggests its utility as a comprehensive diagnostic imaging tool.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What are the specific clinical indications for use of the Kosmos system, particularly differentiating its applications within the listed product codes (IYN, IYO, ITX, DQD, DPS, QIH)?; What are the key performance specifications of the Kosmos device, such as imaging resolution, Doppler sensitivity, penetration depth, and transducer frequency ranges?; How does the Kosmos system integrate its various components (e.g., pulsed Doppler, pulsed echo, transducers, image processing software) to enhance diagnostic capabilities compared to predicate devices?; Are there specific software features, such as AI-driven analysis or advanced quantification tools (implied by QIH product code), included with the Kosmos system?; What clinical studies or bench testing data support the performance and diagnostic accuracy of the Kosmos device across its intended range of ultrasonic imaging applications?